首页> 外文期刊>Gene therapy >Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector.
【24h】

Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector.

机译:皮质脊髓束转导:七个腺相关病毒载体血清型和非整合型慢病毒载体的比较。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The corticospinal tract (CST) is extensively used as a model system for assessing potential therapies to enhance neuronal regeneration and functional recovery following spinal cord injury (SCI). However, efficient transduction of the CST is challenging and remains to be optimised. Recombinant adeno-associated viral (AAV) vectors and integration-deficient lentiviral vectors are promising therapeutic delivery systems for gene therapy to the central nervous system (CNS). In the present study the cellular tropism and transduction efficiency of seven AAV vector serotypes (AAV1, 2, 3, 4, 5, 6, 8) and an integration-deficient lentiviral vector were assessed for their ability to transduce corticospinal neurons (CSNs) following intracortical injection. AAV1 was identified as the optimal serotype for transducing cortical and CSNs with green fluorescent protein (GFP) expression detectable in fibres projecting through the dorsal CST (dCST) of the cervical spinal cord. In contrast, AAV3 and AAV4 demonstrated a low efficacy for transducing CNS cells and AAV8 presented a potential tropism for oligodendrocytes. Furthermore, it was shown that neither AAV nor lentiviral vectors generate a significant microglial response. The identification of AAV1 as the optimal serotype for transducing CSNs should facilitate the design of future gene therapy strategies targeting the CST for the treatment of SCI.
机译:皮质脊髓束(CST)被广泛用作评估潜在疗法以增强脊髓损伤(SCI)后神经元再生和功能恢复的模型系统。但是,CST的有效转导具有挑战性,并且有待优化。重组腺相关病毒(AAV)载体和整合缺陷型慢病毒载体是用于基因治疗中枢神经系统(CNS)的有前途的治疗性递送系统。在本研究中,评估了7种AAV血清型(AAV1、2、3、4、5、6、8)和整合缺陷型慢病毒载体的细胞向性性和转导效率,其转导皮质脊髓神经元(CSN)的能力如下皮层内注射。 AAV1被确定为转导皮质和CSNs的最佳血清型,在通过颈脊髓背侧CST(dCST)投射的纤维中可检测到绿色荧光蛋白(GFP)表达。相反,AAV3和AAV4在转导CNS细胞方面显示出低效,而AAV8在少突胶质细胞方面表现出潜在的向性。此外,已表明AAV和慢病毒载体均不产生显着的小胶质细胞应答。将AAV1鉴定为转导CSN的最佳血清型应有助于设计针对CST的未来基因治疗策略,以治疗SCI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号